Differentially expressed angiogenic genes in diabetic erectile tissue - Results from a microarray screening

Molecular Genetics and Metabolism

Volumn 105, Issue 2, 2012, Pages 255-262

  Castela, Ângela ^a,b   Soares, Raquel ^b   Rocha, Fátima ^b   Medeiros, Rui ^c   Ribeiro, Ricardo ^c   Monteiro, Cátia ^c   Gomes, Pedro ^b   Vendeira, Pedro ^a,d   Virag, Ronald ^e   Costa, Carla ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e Centre d'Explorations et Traitements de l'Impuissance (CETI)   (France)

Author keywords

Angiogenesis; Diabetes; Erectile dysfunction; Immunohistochemistry; Microarrays; Real time PCR

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; EOTAXIN; GUANILATE CYCLASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NATRIURETIC PEPTIDE RECEPTOR 1; NEUROPILIN 1; PLATELET DERIVED GROWTH FACTOR ALPHA; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 1; PROTEIN; PROTEIN C FOS; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 12; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN RECEPTOR 1;

ADULT; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; DOWN REGULATION; ERECTILE DYSFUNCTION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; CORPUS CALLOSUM; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM; ERECTILE DYSFUNCTION; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

RATTUS NORVEGICUS;

EID: 84856080147     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.11.002     Document Type: Article

References (31)

1. Sáenz de Tejada I., Angulo J., Cellek S., González-Cadavid N., Heaton J., Pickard R., Simonsen U. Pathophysiology of erectile dysfunction. J. Sex. Med. 2005, 2:26-39.
2. Zúrová-Nedelcevová J., Navarová J., Drábiková K., Jancinová V., Petríková M., Bernátová I., Kristová V., Snirc V., Nosál'ová V., Sotníková R. Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol. Lett. 2006, 27:168-171.
3. Bakker W., Eringa E.C., Sipkema P., van Hinsbergh V.W. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009, 335:165-189.
4. Costa C., Soares R., Castela A., Adães S., Hastert V., Vendeira P., Virag R. Increased endothelial apoptotic cell density in human diabetic erectile tissue - comparison with clinical data. J. Sex. Med. 2009, 6:826-835.
5. Hartge M.M., Kintscher U., Unger T. Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol. Metab. Clin. North Am. 2006, 35:551-5ix.
6. Kirby M., Jackson G., Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease. Int. J. Clin. Pract. 2005, 59:225-229.
7. Xu J., Zou M.H. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 2009, 120:1266-1286.
8. Nessar A. Advanced glycation end products-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67:3-21.
9. Musicki B., Kramer M.F., Becker R.E., Burnett A.L. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. USA 2005, 102:11870-11875.
10. Folkman J. Fundamental concepts of the angiogenic process. Curr. Mol. Med. 2003, 3:643-651.
11. Jesmin S., Sakuma I., Salah-Eldin A., Nonomura K., Hattori Y., Kitabatake A. Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J. Mol. Endocrinol. 2003, 31:401-418.
12. Yamanaka M., Shirai M., Shiina H., Tanaka Y., Enokida H., Tsujimura A., Matsumiya K., Okuyama A., Dahiya R. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J. Urol. 2005, 173:318-323.
13. Jin H.R., Kim W.J., Song J.S., Piao S., Tumurbaatar M., Shin S.H., Choi M.J., Tuvshintur B., Song K.M., Kwon M.H., Yin G.N., Koh G.Y., Ryu J.K., Suh J.K. Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for erectile dysfunction in the type II diabetic db/db mouse. J. Sex. Med. 2010, 7:3635-3646.
14. Catalán V., Gómez-Ambrosi J., Rodríguez A., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J., Frühbeck G. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol. (Oxf) 2008, 68:213-219.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(δδCT) method. Methods 2001, 25:402-408.
16. Ruifrok A.C., Johnston D.A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 2001, 23:291-299.
17. Dey J., Shepherd M.D. Evaluation and treatment of erectile dysfunction in men with diabetes mellitus. Mayo Clin. Proc. 2002, 77:276-282.
18. Babu P.V., Sabitha K.E., Shyamaladevi C.S. Therapeutic effect of green tea extract on advanced glycation and cross-linking of collagen in the aorta of streptozotocin diabetic rats. Clin. Exp. Pharmacol. Physiol. 2006, 33:351-357.
19. Sullivan C.J., Teal T.H., Luttrell I.P., Tran K.B., Peters M.A., Wessells H. Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats. Physiol. Genomics 2005, 23:192-205.
20. Hipp J.D., Davies K.P., Tar M., Valcic M., Knoll A., Melman A., Christ G.J. Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases. BJU Int. 2007, 99:418-430.
21. Bivalacqua T.J., Usta M.F., Champion H.C., Leungwattanakij S., Dabisch P.A., McNamara D.B., Kadowitz P.J., Hellstrom W.J. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int. J. Impot. Res. 2004, 16:21-29.
22. Yang H., Scheff A.J., Schalch D.S. Effects of streptozotocin-induced diabetes mellitus on growth and hepatic insulin-like growth factor I gene expression in the rat. Metabolism 1990, 39:295-301.
23. Wu Q.H., Chen W.S., Chen Q.X., Wang J.H., Zhang X.M. Changes in the expression of platelet-derived growth factor in astrocytes in diabetic rats with spinal cord injury. Chin. Med. J. (Engl) 2010, 123:1577-1581.
24. Marrachelli V.G., Miranda F.J., Centeno J.M., Miranda I., Castelló-Ruiz M., Burguete M.C., Jover-Mengual T., Salom J.B., Torregrosa G., Alborch E. Mechanisms underlying the diabetes-induced hyporeactivity of the rabbit carotid artery to atrial natriuretic peptide. Pharmacol. Res. 2011, 63:190-198.
25. Fang C., Jiang Z., Tomlinson D.R. Expression of constitutive cyclo-oxygenase (COX-1) in rats with streptozotocin-induced diabetes; effects of treatment with evening primrose oil or an aldose reductase inhibitor on COX-1 mRNA levels. Prostaglandins Leukot. Essent. Fatty Acids 1997, 56:157-163.
26. Pu W.Y., Hu L.Q., Wang H.P., Luo Y.X., Wang X.H. Improvement in erectile dysfunction after insulin-like growth factor-1 gene therapy in diabetic rats. Asian J. Androl. 2007, 9:83-91.
27. Rabinovsky E.D., Draghia-Akli R. Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Mol. Ther. 2004, 9:46-55.
28. Kim M., Hwang E.C., Park I.K., Park K. Insulin-like growth factor-1 gene delivery may enhance the proliferation of human corpus cavernosal smooth muscle cells. Urology 2010, 76:511.e5-9.
29. Kuhn M., Völker K., Schwarz K., Carbajo-Lozoya J., Flögel U., Jacoby C., Stypmann J., van Eickels M., Gambaryan S., Hartmann M., Werner M., Wieland T., Schrader J., Baba H.A. The natriuretic peptide/guanylyl cyclase-a system functions as a stress-responsive regulator of angiogenesis in mice. J. Clin. Invest. 2009, 119:2019-2030.
30. Andrade E., Andrade P.M., Borra R.C., Claro J., Srougi M. cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil. BJU Int. 2008, 101:508-512.
31. Nishikimi T., Inaba-Iemura C., Ishimura K., Tadokoro K., Koshikawa S., Ishikawa K., Akimoto K., Hattori Y., Kasai K., Minamino N., Maeda N., Matsuoka H. Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul. Pept. 2009, 154:44-53.